|
| Press Releases |
|
 |
|
| Monday, December 5, 2022 |
|
|
Cohen Milstein Files Lawsuit on Behalf of Northwest Biotherapeutics Against Major Market Makers for Market Manipulation |
| Northwest Biotherapeutics (OTCQB:NWBO) filed a lawsuit against some of the largest and most influential market makers in the world, including Citadel Securities LLC, Canaccord Genuity LLC, G1 Execution Services LLC (a subsidiary of Susquehanna International Group), GTS Securities LLC, Virtu Americas LLC (including Knight Securities), Instinet LLC, and Score Priority Corp, alleging repeated manipulation of the company's stock over five years. more info >> |
|
| Saturday, December 3, 2022 |
|
|
Cohen Milstein代表Northwest Biotherapeutics對主要做市商操縱市場提起訴訟 |
| 今天，Northwest Biotherapeutics（OTCQB：NWBO）對世界上一些最大和最有影響力的做市商提起訴訟，包括 Citadel Securities LLC、Canaccord Genuity LLC、G1 Execution Services LLC（Susquehanna International Group 的子公司）、GTS Securities LLC、Virtu Americas LLC（包括 Knight Securities）、Instinet LLC 和 Score Priority Corp，指控這些公司在五年內反复操縱股票。 more info >> |
|
|
Cohen Milstein代表Northwest Biotherapeutics对主要做市商操纵市场提起诉讼 |
| 今天，Northwest Biotherapeutics（OTCQB：NWBO）对世界上一些最大和最有影响力的做市商提起诉讼，包括 Citadel Securities LLC、Canaccord Genuity LLC、G1 Execution Services LLC（Susquehanna International Group 的子公司）、GTS Securities LLC、Virtu Americas LLC（包括 Knight Securities）、Instinet LLC 和 Score Priority Corp，指控这些公司在五年内反复操纵股票。 more info >> |
|
| Friday, December 2, 2022 |
|
|
Cohen Milstein Files Lawsuit on Behalf of Northwest Biotherapeutics Against Major Market Makers for Market Manipulation |
| Today, Northwest Biotherapeutics (OTCQB:NWBO) filed a lawsuit against some of the largest and most influential market makers in the world, including Citadel Securities LLC, Canaccord Genuity LLC, G1 Execution Services LLC (a subsidiary of Susquehanna International Group), GTS Securities LLC, Virtu Americas LLC (including Knight Securities), Instinet LLC, and Score Priority Corp, alleging repeated manipulation of the company's stock over five years. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
TANAKA Develops World's First High-Performance Palladium Hydrogen Permeable Membrane Exhibiting High Hydrogen Purification Performance at Temperatures around 100 degrees C
Mar 5, 2026 22:00 JST
|
|
|
美國馬球協會擴大大學合作計畫 2026賽季隊伍數創紀錄達70支
Mar 5, 2026 20:00 HKT/SGT
|
|
|
美国马球协会扩大大学合作计划，2026赛季参赛队伍创纪录达70支
Mar 5, 2026 20:00 HKT/SGT
|
|
|
U.S. Polo Assn. Expands Collegiate Partnership Program to Record 70 Teams for 2026 Season
Mar 5, 2026 20:00 HKT/SGT
|
|
|
Lancaster Resources Announces Resignation of Penny White and the Addition of Rob Heaslop to the Board of Directors
Mar 5, 2026 17:29 HKT/SGT
|
|
|
CMS (867.HK/8A8.SG): Self-Developed INHBE-Targeting siRNA Drug Received IND Approval for Overweight/Obesity
Mar 5, 2026 17:00: JST
|
|
|
CMS (867.HK/8A8.SG): Self-Developed INHBE-Targeting siRNA Drug Received IND Approval for Overweight/Obesity
Mar 5, 2026 16:00 HKT/SGT
|
|
|
Honda to Begin Sales of Two U.S.-built Vehicles in Japan
Mar 5, 2026 16:47 JST
|
|
|
DOCOMO's New Haptic-sharing System Enables Fans to Feel Closer to Idols
Mar 5, 2026 16:38 JST
|
|
|
Galaxy Corporation Leads "K-Entertech" IPO Rush as Nasdaq Vice Chairman's Surprise Visit Boosts Listing Prospects
Mar 5, 2026 15:30 HKT/SGT
|
|
|
康哲药业自研INHBE小核酸药物获批超重/肥胖临床
Mar 5, 2026 15:13 HKT/SGT
|
|
|
康哲藥業自研INHBE小核酸藥物獲批超重/肥胖臨床
Mar 5, 2026 15:02 HKT/SGT
|
|
|
Formerra 任命 Tom Kelly 為首席執行官
Mar 5, 2026 14:11 HKT/SGT
|
|
|
富士通Japan、大分市民図書館において「デジタル認証アプリ」を活用したWeb利用者登録サービスを構築し、運用を開始
Mar 5, 2026 13:25: JST
|
|
|
Honda、米国生産乗用車の日本導入を決定
Mar 5, 2026 12:50: JST
|
|
|
|
|
More News >> |
|
|
|
|
|
